Global Clinical Trials in India: Advancing Clinical Research
                     Global Clinical Trials in India: How to Build 
an Effective Study Strategy
Conducting global clinical trials in India successfully requires more than selecting a 
country and opening clinical trial sites. Sponsors need a structured strategy 
covering feasibility, regulatory planning, recruitment, site management, quality, 
and data.
Start With Country Feasibility
Before selecting India, sponsors should assess whether the target disease 
population is available and whether appropriate research sites exist.
Country feasibility should consider therapeutic area, patient demographics, study 
complexity, competing trials, and infrastructure.
Develop a Regulatory Strategy
Regulatory requirements should be assessed early. Understanding the applicable 
requirements helps sponsors prepare appropriate documentation and plan realistic 
timelines.
Select the Right Sites
Site quality can directly influence recruitment and data quality. Sponsors 
should evaluate investigators, infrastructure, staff capacity, patient access, 
and previous performance.
Build a Recruitment Plan
Recruitment targets should be based on site-specific evidence.
A strong plan should identify potential recruitment barriers and establish methods 
for screening, patient engagement, and retention.
Establish Quality Processes
Quality management should begin before the first patient is enrolled.
Training, monitoring, documentation, informed consent, safety reporting, 
and protocol compliance should all be addressed through clearly defined 
processes.
Coordinate Global and Local Teams
Multinational trials involve teams across multiple countries. Clear communication 
between the sponsor, CRO, investigators, laboratories, and other vendors is 
essential.
Responsibilities should be clearly defined to avoid duplication and communication 
gaps.
Monitor Study Performance
Regular review of recruitment, protocol deviations, data queries, safety 
events, and site performance can help identify emerging risks.
Early intervention is generally easier than addressing significant problems 
later in the study.
Prepare for Study Closeout
Database cleaning, site closeout, document reconciliation, investigational product 
accountability, and final reporting should be planned from the beginning.
A structured approach can help sponsors maximize the potential of global clinical 
trials in India. By combining country feasibility, regulatory planning, appropriate site 
selection, recruitment strategy, quality oversight, and strong communication, 
sponsors can create a more reliable foundation for successful clinical development.